JACLYN HARRIS: Open Payments
NPI 1184071359 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 24 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $289 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $120 |
| SOBI, INC | 3 | $85 |
| Deciphera Pharmaceuticals Inc. | 2 | $61 |
| ARRAY BIOPHARMA INC | 2 | $36 |
| Genmab U.S., Inc. | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
| KYOWA KIRIN, INC. | 1 | $26 |
| SERVIER PHARMACEUTICALS LLC | 1 | $25 |
| Incyte Corporation | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: Doptelet, DARZALEX, BRAFTOVI, RUBRACA, RYBREVANT, Epkinly, ERLEADA, Enhertu.
Industry payments across TX — which companies pay providers there.
